New, less invasive surgery for early stomach cancer shows promise in small trial

NCT ID NCT07295002

Not yet recruiting Disease control Sponsor: Region Stockholm Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a less invasive surgical approach for people with early gastric cancer who need additional treatment after an initial endoscopic removal. The procedure uses a special dye to guide removal of nearby lymph nodes, with or without removing a small part of the stomach. The trial will include 10 participants and focus on safety and complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Indocyanine Green (ICG) dye injection and laparoscopic surgery
What this could lead to: If successful, this could offer a less invasive surgical option for early gastric cancer patients, reducing recovery time and complications.
What could go wrong: This is a very small early trial with only 10 participants, so results may not apply to all patients. The procedure still carries risks like bleeding or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EARLY GASTRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric neoplasm microinvasive gastric cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EARLY GASTRIC CANCER

Contacts and locations

Locations

Karolinska University Hospital Huddinge

Stockholm, 141 57, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.